ClinicalTrials.Veeva

Menu

Vaping Adverse Lung and Heart Events Cohort (VapALERT)

L

Laval University

Status

Enrolling

Conditions

Electronic Cigarette Use
Vaping

Treatments

Other: Vaping

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.

Full description

Daily vaping device users will be recruited in the Quebec City metropolitan area. Subjects will be asked to perform pulmonary function tests (spirometry, oscillometry, plethysmography, methacholine provocation) every 6 months for a 5-year follow up. Subjects will also answer a questionnaire assessing their vaping, tobacco and cannabis smoking habits, as well as their perceived respiratory symptoms. Blood draws and sputum inductions will be performed for cell counts and to measure inflammation markers.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Daily electronic cigarette user
  • No respiratory infection in the 4 weeks before a visit

Exclusion criteria

  • Women who are pregnant or breast-feeding.

Trial design

250 participants in 1 patient group

Daily electronic cigarette users
Description:
Participants must use their vaping device everyday at time of enrollment.
Treatment:
Other: Vaping

Trial contacts and locations

1

Loading...

Central trial contact

Mathieu C Morissette, PhD; Ariane Lechasseur, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems